Waters Corporation $WAT Stock: Russell Investments Group Ltd. Lowers Position

Russell Investments Group Ltd. cut its stake in shares of Waters Corporation (NYSE:WAT – Free Report) by 6.2% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 88,770 shares of the medical instruments supplier’s stock after selling 5,888 shares during the period. Russell Investments Group Ltd. owned 0.09% of Waters worth $39,043,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Resources Management Corp CT ADV acquired a new stake in Waters during the 1st quarter worth approximately $27,000. Westside Investment Management Inc. acquired a new position in Waters during the third quarter valued at approximately $27,000. PenderFund Capital Management Ltd. purchased a new stake in Waters during the second quarter worth approximately $28,000. Vision Retirement LLC purchased a new stake in Waters during the first quarter worth approximately $29,000. Finally, Bollard Group LLC purchased a new stake in Waters during the first quarter worth approximately $29,000. 94.01% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Wells Fargo & Company increased their price objective on shares of Waters from $370.00 to $400.00 and gave the stock an “equal weight” rating in a research report on Wednesday, August 5th. UBS Group upgraded shares of Waters from a “neutral” rating to a “buy” rating and lifted their target price for the company from $375.00 to $490.00 in a report on Wednesday, September 9th. Morgan Stanley set a $430.00 price target on shares of Waters in a research report on Wednesday, August 5th. Leerink Partners increased their price target on Waters from $420.00 to $450.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Finally, Robert W. Baird increased their price target on Waters from $456.00 to $495.00 and gave the company an “outperform” rating in a report on Thursday, October 8th. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $475.48.

Check Out Our Latest Research Report on Waters

Waters Stock Performance

Waters stock opened at $452.74 on Tuesday. The firm has a market capitalization of $44.50 billion, a PE ratio of 194.31, a price-to-earnings-growth ratio of 2.63 and a beta of 1.16. Waters Corporation has a one year low of $282.77 and a one year high of $483.33. The stock’s 50 day moving average price is $441.32 and its 200 day moving average price is $374.46. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.40 and a current ratio of 1.89.

Waters (NYSE:WAT – Get Free Report) last issued its quarterly earnings data on Tuesday, November 3rd. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.00 by $0.10. Waters had a net margin of 1.75% and a return on equity of 9.91%. The company had revenue of $1.77 billion during the quarter, compared to the consensus estimate of $1.75 billion. During the same quarter last year, the company earned $3.40 earnings per share. Waters’s revenue for the quarter was up 120.9% on a year-over-year basis. As a group, sell-side analysts expect that Waters Corporation will post 14.65 EPS for the current fiscal year.

About Waters

(Free Report)

Waters Corporation develops and supplies analytical instruments, software, and consumables used to identify, measure, and characterize chemical and biological materials. Its products include liquid chromatography and mass spectrometry systems, which help customers analyze complex samples. The company serves pharmaceutical and biotechnology businesses, academic and government laboratories, and customers in fields such as food, environmental testing, and materials science. Waters operates internationally, with customers and operations across multiple regions.

Further Reading

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT – Free Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.